Financial Performance - The company's operating revenue for 2021 was CNY 305,100,698.16, representing a 4.12% increase compared to CNY 293,031,489.79 in 2020[21] - The net profit attributable to shareholders of the listed company was CNY 69,818,620.85, a slight increase of 0.71% from CNY 69,329,803.17 in the previous year[21] - The operating profit for 2021 was CNY 82,670,380.50, which is an increase of 0.75% compared to the previous year[28] - Basic earnings per share for 2021 were CNY 1.21, a slight increase from CNY 1.20 in 2020[23] - The company reported a weighted average return on equity of 14.30%, down 2.35 percentage points from 16.65% in 2020[23] - The company reported a total current liability of CNY 201,630,172.30 in 2021, compared to CNY 126,890,097.81 in 2020, an increase of about 58.7%[170] - The company's total liabilities and equity amounted to CNY 731,052,294.26 in 2021, up from CNY 579,168,502.81 in 2020, indicating an overall growth of approximately 26.2%[170] Cash Flow - The net cash flow from operating activities decreased by 47.98% to CNY 32,752,277.57, down from CNY 62,959,083.21 in 2020[22] - The company’s net cash flow from operating activities was CNY -101,467,018.67 for the year[25] - The company reported a net cash flow from financing activities of CNY 37,730,050.45, primarily due to new loans taken during the period[46] - The net cash flow from operating activities decreased due to increased payments for material procurement, employee compensation, and various taxes[46] - Cash inflow from financing activities surged by 206.44% to ¥51,788,000.00, primarily due to new working capital loans[57] - The ending cash and cash equivalents balance for 2021 was ¥220,914,453.13, an increase of 23.2% from ¥179,300,204.25 in 2020[183] Assets and Liabilities - The total assets at the end of 2021 reached CNY 731,052,294.26, marking a 26.22% increase from CNY 579,168,502.81 at the end of 2020[22] - The net assets attributable to shareholders of the listed company increased by 15.96% to CNY 524,166,850.02, compared to CNY 452,028,405.00 at the end of 2020[22] - Total liabilities reached CNY 206,885,444.24 in 2021, compared to CNY 127,140,097.81 in 2020, indicating an increase of about 62.4%[170] - Owner's equity rose to CNY 524,166,850.02 in 2021, up from CNY 452,028,405.00 in 2020, reflecting a growth of approximately 15.9%[170] Research and Development - The company’s R&D efforts focused on enhancing product development capabilities and establishing a collaborative innovation model with universities and research institutions[30] - Research and development expenses decreased by 15.21%, totaling ¥8,448,396.20, compared to ¥9,963,608.37 in the previous year[45] - R&D expenses totaled ¥14,712,398.26, representing 4.82% of operating revenue, with no capitalized R&D expenditures[54] - The company has established a comprehensive research and production integration system, achieving significant results in complex precision electromechanical hydraulic equipment[41] Market and Product Development - The company has enhanced its product line, focusing on aircraft ground support equipment and related manufacturing, which has improved its order acquisition capabilities[42] - The company is actively pursuing market expansion opportunities in the aerospace and defense sectors, driven by national policies promoting military-civilian integration[34] - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of 300 million yuan allocated for potential deals[98] - The company plans to enhance collaboration across various business units to improve the development and manufacturing of aviation ground support equipment and components[74] Governance and Compliance - The company has established a complete corporate governance structure, ensuring independence from the controlling shareholder[92] - Information disclosure was conducted in accordance with laws and regulations, with no instances of false records or significant omissions[90] - The company maintained independence from its controlling shareholder in assets, personnel, finance, and operations, ensuring no interference in management decisions[89] - The company has not faced any penalties from securities regulatory agencies in the past three years[103] Employee and Social Responsibility - The company has established a comprehensive employee training system, focusing on management, technology, and health[113] - Employee rights are protected in accordance with national regulations, with a comprehensive social security system in place[126] - The company actively engaged in social responsibility initiatives, including pandemic prevention measures, ensuring a 100% vaccination rate among employees[127] Future Outlook - The company aims to achieve a stable and progressive growth strategy for 2022, with specific operational goals and responsibilities assigned[73] - The company provided a future outlook, projecting a revenue growth of 10% for the next quarter, aiming for 1.32 billion yuan[98] - New product launches are expected to contribute an additional 200 million yuan in revenue over the next six months[98] - The management emphasized the importance of sustainability initiatives, with a commitment to reduce carbon emissions by 25% over the next five years[98]

Financial Performance - The company's operating revenue for Q1 2022 was CNY 33,602,448.83, representing a year-on-year increase of 176.79%[4] - The net profit attributable to shareholders for Q1 2022 was CNY 2,450,944.75, an increase of 156.13% compared to the same period last year[4] - Basic earnings per share for Q1 2022 reached CNY 0.40, reflecting a significant increase of 600% year-on-year[4] - Total revenue for Q1 2022 reached ¥33,602,448.83, a significant increase of 176.5% compared to ¥12,140,020.46 in Q1 2021[15] - Operating profit for Q1 2022 was ¥2,870,267.86, recovering from a loss of ¥5,032,475.81 in Q1 2021[16] - Net profit for Q1 2022 was ¥2,450,944.75, compared to a net loss of ¥4,366,803.29 in the same period last year[16] - Basic and diluted earnings per share for Q1 2022 were both ¥0.40, a turnaround from a loss of ¥0.08 per share in Q1 2021[17] Assets and Liabilities - Total assets at the end of Q1 2022 amounted to CNY 1,032,083,033.65, up 41.18% from the end of the previous year[5] - Current assets totaled ¥875,366,448.03, up from ¥588,406,406.63 year-over-year, indicating a growth of approximately 48.8%[13] - Total liabilities decreased to ¥170,273,510.98 from ¥206,885,444.24, a reduction of about 17.7%[14] - Owner's equity increased significantly to ¥861,809,522.67 from ¥524,166,850.02, showing a growth of approximately 64.3%[14] - The total current liabilities were ¥165,375,068.47, down from ¥201,630,172.30, indicating a decrease of about 17.9%[14] - The total assets and liabilities amounted to ¥1,032,083,033.65 and ¥861,809,522.67 respectively as of March 31, 2022[15] Cash Flow - The company's cash flow from operating activities showed a net outflow of CNY -106,812,459.79, a decrease of 5.27% year-on-year[4] - Cash flow from operating activities showed a net outflow of ¥106,812,459.79, slightly worse than the outflow of ¥101,467,018.67 in Q1 2021[18] - Cash flow from investing activities resulted in a net outflow of ¥20,522,643.52, compared to a net outflow of ¥13,417,199.35 in the previous year[19] - Cash flow from financing activities generated a net inflow of ¥350,280,991.32, contrasting with a net outflow of ¥96,250.00 in Q1 2021[19] - The total cash and cash equivalents at the end of Q1 2022 amounted to ¥443,862,341.14, up from ¥64,319,736.23 at the end of Q1 2021[19] - The net cash flow from operating activities was -$121,923,121.88, compared to -$97,011,915.14 in the previous year[28] - The net cash flow from investing activities was -$4,276,090.02, an improvement from -$14,164,879.35 year-over-year[28] - The net cash flow from financing activities was $350,299,999.99, a significant increase from -$96,250.00 in the previous year[28] - The total cash and cash equivalents at the end of the period amounted to $440,048,986.36, up from $59,200,045.08 year-over-year[28] Research and Development - Research and development expenses for Q1 2022 were CNY 3,057,853.52, marking a 62.30% increase compared to the previous year[6] - Research and development expenses for Q1 2022 were ¥3,057,853.52, an increase from ¥1,884,078.65 in Q1 2021, indicating a focus on innovation[16] - Research and development expenses for Q1 2022 were CNY 2,588,469.24, up from CNY 1,884,078.65 in Q1 2021, indicating an increase of 37.2%[24] Accounts Receivable and Payable - The company reported a significant increase in accounts receivable, which rose by 1814.58% to CNY 5,604,931.60 due to increased operating revenue[5] - Accounts receivable increased to ¥194,578,413.58 from ¥175,290,331.38, reflecting an increase of about 11%[12] - The company reported a decrease in accounts payable to CNY 75,733,112.16 in Q1 2022, down from CNY 103,388,573.27 in Q1 2021, a reduction of 26.7%[23] Financing Activities - The company raised CNY 350,280,991.32 from financing activities in Q1 2022, a dramatic increase of 364028.30% year-on-year[7] - The company executed the new accounting standards starting from 2022, which may impact financial reporting[28] - The cash inflow from investment activities included $10,000,000.00 in cash payments for investments[28] - The company’s cash flow management shows a positive trend with a significant increase in cash reserves[28]

Financial Performance - The company's operating revenue for 2021 was CNY 305,100,698.16, representing a 4.12% increase compared to CNY 293,031,489.79 in 2020[21]. - The net profit attributable to shareholders for 2021 was CNY 69,818,620.85, a slight increase of 0.71% from CNY 69,329,803.17 in 2020[21]. - The net profit after deducting non-recurring gains and losses was CNY 66,467,531.40, showing a decrease of 0.97% compared to CNY 67,120,660.22 in 2020[22]. - The company achieved operating revenue of CNY 305,100,698.16 in 2021, representing a year-on-year growth of 4.12%[31]. - The company reported a basic earnings per share of CNY 1.21, a slight increase of 0.83% compared to the previous year[23]. - The total operating revenue for 2021 reached ¥305,100,698.16, an increase of 4.6% compared to ¥293,031,489.79 in 2020[182]. - The total profit for 2021 was CNY 82,681,767.53, up from CNY 81,888,569.65 in 2020, reflecting a growth of 0.97%[183]. - The total comprehensive income for 2021 was CNY 69,818,620.85, compared to CNY 69,329,803.17 in 2020, showing a slight increase of 0.7%[184]. Cash Flow and Assets - The net cash flow from operating activities decreased by 47.98% to CNY 32,752,277.57 from CNY 62,959,083.21 in 2020[22]. - The total assets at the end of 2021 were CNY 731,052,294.26, reflecting a 26.22% increase from CNY 579,168,502.81 at the end of 2020[22]. - The company's cash and cash equivalents stood at CNY 220.9165 million, up from CNY 179.3062 million, representing a growth of about 23.2% year-over-year[173]. - The net cash flow from operating activities decreased by 47.98% year-on-year, totaling ¥32.75 million, while cash inflows increased by 11.97% to ¥299.81 million[57]. - The company's cash flow from financing activities generated a net inflow of CNY 38,595,763.87, compared to CNY 14,209,275.73 in the previous year, representing a significant increase of approximately 171.5%[193]. Research and Development - The company focused on enhancing its research and development capabilities through collaboration with well-known domestic universities and research institutions[33]. - The total R&D expenditure amounted to ¥14.71 million, representing 4.82% of the total revenue, with no capitalized R&D expenses[55]. - Research and development expenses decreased to CNY 7,664,260.74 in 2021 from CNY 9,866,833.74 in 2020, a reduction of 22.3%[185]. Governance and Compliance - The company has a standard unqualified audit report from the accounting firm Xin Yong Zhong He[4]. - The company maintains independence from its controlling shareholder in terms of assets, personnel, finance, and operations, ensuring no interference in management decisions[84]. - The company has established a robust investor relations management mechanism, ensuring accurate and complete disclosure of information without misleading statements[85]. - The company has established specialized committees under the board, including the audit committee, nomination committee, compensation and assessment committee, and strategic committee[101]. - The company has not faced any penalties from securities regulatory authorities in the past three years[98]. Market Position and Strategy - The company achieved a significant increase in its market share in the high-end equipment sector, with core technology dependency on external sources significantly reduced[36]. - The company is positioned to benefit from national policies promoting the integration of military and civilian industries, enhancing its growth prospects in the defense sector[35]. - The company is focused on expanding its market presence in civilian products to reduce reliance on military contracts[75]. - The company has plans for market expansion and potential mergers and acquisitions, aiming to enhance its competitive position in the industry[93]. Employee and Talent Management - The company emphasizes talent development through a combination of internal and external training, fostering a positive environment for employee growth[42]. - The company has established a comprehensive employee training system, focusing on management, technology, and health, to enhance employee capabilities[108]. - The company has a strict compensation policy that links salaries to overall company performance and individual assessments, aiming to attract and retain talent[107]. Risks and Challenges - There are no significant risks that could materially affect the company's operations during the reporting period[8]. - The company faces risks related to high customer concentration, primarily serving units under the aviation industry[75]. - The company has established a COVID-19 prevention and control leadership group to mitigate risks associated with the pandemic[75].